Development and validation pathways of artificial intelligence tools evaluated in randomised clinical trials

OBJECTIVE: Given the complexities of testing the translational capability of new artificial intelligence (AI) tools, we aimed to map the pathways of training/validation/testing in development process and external validation of AI tools evaluated in dedicated randomised controlled trials (AI-RCTs). M...

Descripción completa

Detalles Bibliográficos
Autores principales: Siontis, George C M, Sweda, Romy, Noseworthy, Peter A, Friedman, Paul A, Siontis, Konstantinos C, Patel, Chirag J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718483/
https://www.ncbi.nlm.nih.gov/pubmed/34969668
http://dx.doi.org/10.1136/bmjhci-2021-100466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718483/
https://www.ncbi.nlm.nih.gov/pubmed/34969668
http://dx.doi.org/10.1136/bmjhci-2021-100466

Ejemplares similares